Cross-Clade Reactivity of HIV-1-Specific T-cell Responses in HIV-1-Infected Individuals From Botswana and Cameroon

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Acquired Immune Deficiency Syndromes

• Publication date

  2006-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/01.qai.0000223017.01568.e7PMID 16760794
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents.

  2005cited by this paper
• HIV Infections in Northwestern Cameroon: Identification of HIV Type 1 Group O and Dual HIV Type 1 Group M and Group O Infections

  2004cited by this paper
• Genetic Diversity of HIV Type 1 in Rural Eastern Cameroon

  2004cited by this paper
• Immunopathogenesis and immunotherapy in AIDS virus infections

  2003cited by this paper
• HIV T cell vaccines, the importance of clades.

  2002cited by this paper
• Differences Between T Cell Epitopes Recognized After Immunization and After Infection1

  2002cited by this paper
• Estimated Global Distribution and Regional Spread of HIV‐1 Genetic Subtypes in the Year 2000

  2002cited by this paper
• HIV-1 Diversity and Vaccine Development

  2002cited by this paper
• Immune control of HIV: the obstacles of HLA and viral diversity

  2001cited by this paper
• Unprecedented Degree of Human Immunodeficiency Virus Type 1 (HIV-1) Group M Genetic Diversity in the Democratic Republic of Congo Suggests that the HIV-1 Pandemic Originated in Central Africa

  2000cited by this paper
• Containing HIV after infection

  2000cited by this paper

• Epistatic interaction between ERAP2 and HLA modulates HIV-1 adaptation and disease outcome in an Australian population

  2024influential citation
• Construction, Selection and Immunogenicity of Recombinant Fowlpox Candidate Vaccine Co-expressing HIV-1 gag and gp145

  2017cites this paper
• Striking lack of T cell immunodominance in both a multiclade and monoclade HIV-1 epidemic: implications for vaccine development.

  2014cites this paper
• Immunology and virology of HIV-1 infection in Cameroon

  2014cites this paper
• Challenges in the Design of a T Cell Vaccine in the Context of HIV-1 Diversity

  2014cites this paper
• Recombinant Salmonella enterica Serovar Typhimurium as a Vaccine Vector for HIV-1 Gag

  2013cites this paper
• Higher cross-subtype IFN-γ ELISpot responses to Gag and Nef peptides in Brazilian HIV-1 subtype B- and F1- than in C-infected subjects.

  2013cites this paper
• A similarity in peptide cross-reactivity between alloantigen- and nominal antigen-induced CD8+ T cell responses in vitro

  2013cites this paper
• igher cross-subtype IFN-ELISpot responses to Gag and Nef peptides in razilian HIV-1 subtype Band F 1-than in C-infected subjects ernanda

  2012cites this paper
• Characterization of CD4+ and CD8+ T cell responses in HIV-1 C-Clade infection.

  2011cites this paper
• Intra- and Inter-clade Cross-reactivity by HIV-1 Gag Specific T-Cells Reveals Exclusive and Commonly Targeted Regions: Implications for Current Vaccine Trials

  2011cites this paper
• Cross-Reactive T Cell Responses in HIV CRF01_AE and B′-Infected Intravenous Drug Users: Implications for Superinfection And Vaccines

  2009cites this paper
• Use of predictive markers of HIV disease progression in vaccine trials.

  2009cites this paper
• Host HLA B*Allele-Associated Multi-Clade Gag T-Cell Recognition Correlates with Slow HIV-1 Disease Progression in Antiretroviral Therapy-Naïve Ugandans

  2009cites this paper
• Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults.

  2008cites this paper
• Efficient In Vitro Expansion of Human Immunodeficiency Virus (HIV)-Specific T-Cell Responses by gag mRNA-Electroporated Dendritic Cells from Treated and Untreated HIV Type 1-Infected Individuals

  2008cites this paper
• Human Immunodeficiency Virus Type 1 Subtype Distribution in the Worldwide Epidemic: Pathogenetic and Therapeutic Implications

  2007cites this paper
• HIV-1 Subtype C Gag-Specific T-Cell Responses in Relation to Human Leukocyte Antigens in a Diverse Population of HIV-Infected Ethiopians

  2007cites this paper
• Neutralizing antibodies: specificities and breadth Related review: Neutralizing and other antiviral antibodies in HIV-1 infection and vaccination

  2007cites this paper
• Investigating cross-clade immune responses in HIV-1 subtype C-infected individuals from South Africa

  2007cites this paper
• Detection of HIV Vaccine-Induced Cell-Mediated Immunity in HIV-Seronegative Clinical Trial Participants Using an Optimized and Validated Enzyme-Linked Immunospot Assay

  2007cites this paper